4108
J. M. Lopchuk, G. W. Gribble / Tetrahedron Letters 52 (2011) 4106–4108
1992, 57, 1653–1656; (b) Wang, J.; Scott, A. I. Tetrahedron Lett. 1996, 37, 3247–
1.5 Hz), 7.47–7.04 (m, 15H), 6.70–6.67 (m, 2H), 6.62 (s, 1H), 5.13 (s, 2H); 13C
NMR (300 MHz, CDCl3) d 149.1, 146.5, 139.1, 136.3, 134.6, 133.3, 133.2, 132.7,
132.3, 131.4, 129.4, 128.9, 128.8, 128.5, 128.4, 127.7, 127.2, 126.2, 123.24,
120.0, 109.2, 48.8; HRMS (ESI+) m/z calcd for C28H23N2 (MH+) 387.1861, found
387.1862.
3250; (c) Ghosez, L.; Franc, C.; Denonne, F.; Cuisinier, C.; Touillaux, R. Can. J.
Chem. 2001, 79, 1827–1839; (d) Stockman, V.; Eriksen, K. L.; Fiksdahl, A.
Tetrahedron 2008, 64, 11180–11184; (e) Stockman, V.; Bakke, J. M.; Bruheim, P.;
Fiksdahl, A. Tetrahedron 2009, 65, 3668–3672; (f) Fall, Y.; Doucet, H.; Santelli,
M. ChemSusChem 2009, 2, 153–157.
19. 4-(1-Benzyl-2,5-diphenyl-1H-pyrrol-3-yl)pyridine (23): Pale yellow solid, mp
141–142 °C; 1H NMR (300 MHz, CDCl3) d 8.34 (d, 2H, J = 6.1 Hz), 7.45–7.08 (m,
15H), 6.70–6.68 (m, 3H), 5.10 (s, 2H); 13C NMR (300 MHz, CDCl3) d 149.8, 144.0,
138.8, 136.4, 134.2, 133.1, 132.7, 131.3, 129.4, 129.0, 128.8, 128.7, 128.6, 127.9,
127.2, 126.2, 124.1, 121.9, 120.5, 109.1, 48.7; HRMS (ESI+) m/z calcd for
5. (a) Billingsley, K. L.; Anderson, K. W.; Buchwald, S. L. Angew. Chem., Int. Ed.
2006, 45, 3484–3488; (b) Billingsley, K. L.; Buchwald, S. L. J. Am. Chem. Soc.
2007, 129, 3358–3366; (c) Billingsley, K. L.; Buchwald, S. L. Angew. Chem., Int.
Ed. 2008, 47, 4695–4698.
6. For examples with TosMIC, see: (a) Pavri, N. P.; Trudell, M. L. J. Org. Chem. 1997,
62, 2649–2651; (b) Smith, N. D.; Huang, D.; Cosford, N. D. P. Org. Lett. 2002, 4,
3537–3539. and references therein; For an example with isocyanides, see:
Lygin, A. V.; Larionov, O. V.; Korotkov, V. S.; de Meijere, A. Chem. Eur. J. 2009, 15,
227–236; For an example with oxazolidines, see: Deprez, P.; Royer, J.; Husson,
H-P. Synthesis 1991, 759–762; For other methods, see: (a) Katritzky, A. R.; Zhu,
L.; Lang, H.; Denisko, O.; Wang, Z. Tetrahedron 1995, 51, 13271–13276; (b)
Hoemann, M. Z.; Melikian-Badalian, A.; Kumaravel, G.; Hauske, J. R. Tetrahedron
Lett. 1998, 39, 4749–4752; (c) Nishiwaki, N.; Yamashita, K.; Azuma, M.; Adachi,
T.; Tamura, M.; Ariga, M. Synthesis 2004, 1996–2000; (d) Braun, R. U.; Muller, T.
J. J. Synthesis 2004, 2391–2406.
C
28H23N2 (MH+) 387.1861, found 387.1863.
20. 2-(1-Benzyl-2,5-diphenyl-1H-pyrrol-3-yl)quinoline (24): Off-white solid, mp
163–165 °C; 1H NMR (300 MHz, CDCl3) d 8.14 (d, 1H, J = 8.8 Hz), 7.75 (d, 1H,
J = 8.8 Hz), 7.69–7.65 (m, 2H), 7.57–7.55 (d, 2H, J = 6.8 Hz), 7.44–7.32 (m, 9H),
7.22 (s, 1H), 7.12–7.10 (m, 3H), 6.99 (d, 1H, J = 8.5 Hz), 6.72–6.69 (m, 2H), 5.20
(s, 2H); 13C NMR (300 MHz, CDCl3) d 155.5, 148.7, 138.9, 136.6, 135.4, 133.6,
133.2, 131.6, 130.0, 129.5, 129.5, 129.3, 128.9, 128.8, 128.5, 128.2, 127.6, 127.6,
127.1, 126.4, 125.5, 124.6, 121.5, 110.7, 48.9; HRMS (ESI+) m/z calcd for
C
32H25N2 (MH+) 437.2018, found 437.2017.
21. 2-(1-Benzyl-5-methyl-2-phenyl-1H-pyrrol-3-yl)pyridine (25): yellow oil; 1H
NMR (300 MHz, CDCl3) d 8.45 (d, 1H, J = 4.9 Hz), 7.60 (dd, 1H, J = 7.8, 1.5 Hz),
7.42–7.19 (m, 8H), 6.92–6.87 (m, 3H), 6.76 (d, 1H, J = 8.1 Hz), 6.68 (s, 1H), 4.95
(s, 2H), 2.18 (s, 3H); 13C NMR (300 MHz, CDCl3) d 155.3, 149.3, 138.8, 135.8,
133.4, 132.5, 131.4, 130.9, 128.8, 128.7, 128.5, 128.3, 127.2, 126.7, 121.8, 120.0,
107.9, 47.7, 12.7; HRMS (ESI+) m/z calcd for C23H21N2 (MH+) 325.1705, found
325.1705.
7. Gribble, G. W.; Pelkey, E. T.; Simon, W. E.; Trujillo, H. A. Tetrahedron 2000, 56,
10133–10140.
8. Lopchuk, J. M.; Gribble, G. W. Heterocycles 2011, 82, 1617–1631.
9. Nomland, A.; Hills, I. D. Tetrahedron Lett. 2008, 49, 5511–5514.
10. (a) Bourguignon, J.; Le Nard, G.; Queguiner, G. Can. J. Chem. 1985, 63, 2354–
2361; (b) Krafft, E. A.; Kurt, A.; Maier, A.; Thomas, A. W.; Zimmerli, D. Synthesis
2005, 3245–3252.
22. 2-(1-Benzyl-2-methyl-5-phenyl-1H-pyrrol-3-yl)pyridine (26): pale orange oil; 1
H
NMR (300 MHz, CDCl3) d 8.64 (d, 1H, J = 3.9 Hz), 7.66 (t, 1H), 7.52 (d, 1H,
J = 7.8 Hz), 7.41–7.26 (m, 9H), 7.08–7.03 (d, 2H), 6.71 (s, 1H), 5.22 (s, 2H), 2.54
(s, 3H); 13C NMR (300 MHz, CDCl3) d 156.4, 149.4, 138.8, 136.4, 134.8, 133.6,
130.0, 129.1, 128.7, 127.4, 127.3, 126.0, 121.7, 120.0, 108.6, 48.1, 12.1; HRMS
(ESI+) m/z calcd for C23H21N2 (MH+) 325.1705, found 325.1697.
11. Sample procedure:
(60 mg, 0.40 mmol, 1 equiv), münchnone precursor
3 equiv) and anhydrous THF (10 mL, distilled from sodium/benzophenone
immediately prior to use). DIPC (186 L, 1.2 mmol, 3 equiv) was added via
A
round bottom flask was charged with nitroalkene
5
9
(266 mg, 1.2 mmol,
l
syringe and the mixture was refluxed under nitrogen for 24 h. Once TLC
indicated complete consumption of the nitroalkene the reaction was cooled to
room temperature and concentrated in vacuo. The remaining residue was
dissolved in CH2Cl2 and purified by flash chromatography (silica gel, 15% ethyl
acetate in hexanes) to yield pyridylpyrrole 17 (95 mg, 91%).13
23. 3-(1-Benzyl-5-methyl-2-phenyl-1H-pyrrol-3-yl)pyridine (27): pale orange oil; 1
H
NMR (300 MHz, CDCl3) d 8.52 (d, 1H, J = 1.5 Hz), 8.29 (dd, 1H, J = 4.8, 1.7 Hz),
7.42–7.18 (m, 9H), 7.05–7.00 (m, 1H), 6.91 (d, 2H, J = 6.8 Hz), 6.32 (s, 1H), 4.99
(s, 2H), 2.19 (s, 3H); 13C NMR (300 MHz, CDCl3) d 149.0, 146.2, 138.8, 134.5,
132.9, 132.7, 131.3, 130.1, 129.1, 129.0, 129.0, 128.7, 128.6, 128.5, 128.3, 128.2,
128.0, 127.6, 127.3, 107.2, 47.8, 12.7; HRMS (ESI+) m/z calcd for C23H21N2
(MH+) 325.1705, found 325.1700.
12. Computational studies designed to study this regioselectivity will be reported
separately in a full account of this work.
13. 2-(1-Benzyl-2,5-dimethyl-1H-pyrrol-3-yl)pyridine (17): White solid, mp 82–
83 °C; 1H NMR (300 MHz, CDCl3) d 8.61 (d, 1H, J = 4.2 Hz), 7.62 (t, 1H), 7.44
(d, 1H, J = 8.1 Hz), 7.34–7.23 (m, 3H), 7.03–6.97 (m, 3H), 6.36 (s, 1H), 5.10 (s,
2H), 2.55 (s, 3H), 2.21 (s, 3H); 13C NMR (300 MHz, CDCl3) d 156.8, 149.3, 138.2,
136.2, 129.0, 128.4, 127.9, 127.4, 126.0, 121.4, 120.2, 119.5, 106.4, 47.0, 12.6,
11.8; HRMS (ESI+) m/z calcd for C18H19N2 (MH+) 263.1548, found 263.1547.
14. 3-(1-Benzyl-2,5-dimethyl-1H-pyrrol-3-yl)pyridine (18): Pale yellow oil; 1H NMR
(300 MHz, CDCl3) d 8.69 (d, 1H, J = 2.0 Hz), 8.42 (dd, 1H, J = 4.9, 1.5 Hz), 7.69 (dt,
1H, J = 7.8, 3.9 Hz), 7.35–7.25 (m, 4H), 6.95 (d, 2H, J = 7.1 Hz), 6.12 (s, 1H), 5.09
(s, 2H), 2.27 (s, 3H), 2.21 (s, 3H); 13C NMR (300 MHz, CDCl3) d 149.3, 146.3,
138.2, 135.0, 133.5, 129.2, 128.8, 127.5, 125.9, 123.5, 117.6, 106.4, 47.2, 12.5,
11.4; HRMS (ESI+) m/z calcd for C18H19N2 (MH+) 263.1548, found 263.1541.
15. 4-(1-benzyl-2,5-dimethyl-1H-pyrrol-3-yl)pyridine (19): Yellow solid, mp 83–
85 °C; 1H NMR (300 MHz, CDCl3) d 8.50 (d, 2H, J = 4.6 Hz), 7.36–7.23 (m, 5H),
6.92 (d, 2H, J = 7.3 Hz), 6.17 (s, 1H), 5.07 (s, 2H), 2.30 (s, 3H), 2.19 (s, 3H); 13C
NMR (300 MHz, CDCl3) d 149.8, 145.4, 137.9, 129.2, 129.1, 128.6, 127.5, 126.7,
125.8, 125.6, 122.3, 118.4, 106.2, 47.2, 12.5, 11.8; HRMS (ESI+) m/z calcd for
24. 3-(1-Benzyl-2-methyl-5-phenyl-1H-pyrrol-3-yl)pyridine (28): pale orange oil; 1
H
NMR (300 MHz, CDCl3) d 8.74 (d, 1H, J = 1.5 Hz), 8.46 (dd, 1H, J = 4.9, 1.7 Hz),
7.75 (dt, 1H, J = 8.1, 4.1 Hz), 7.40–7.16 (m, 9H), 7.00 (d, 2H, J = 8.1 Hz), 6.45 (s,
1H), 5.20 (s, 2H), 2.27 (s, 3H); 13C NMR (300 MHz, CDCl3) d 149.4, 146.6, 138.7,
135.2, 133.3, 133.2, 131.3, 129.1, 129.0, 128.9, 128.8, 128.2, 127.5, 125.9, 123.5,
108.5, 48.3, 11.6; HRMS (ESI+) m/z calcd for C23H21N2 (MH+) 325.1705, found
325.1703.
25. 4-(1-Benzyl-5-methyl-2-phenyl-1H-pyrrol-3-yl)pyridine (29): pale orange oil; 1
H
NMR (300 MHz, CDCl3) d 8.30 (d, 2H, J = 4.2 Hz), 7.34–7.19 (m, 8H), 7.04 (d, 2H,
J = 6.1 Hz), 6.88 (d, 2H, J = 6.6 Hz), 6.37 (d, 1H, J = 1.0 Hz), 4.95 (s, 2H), 2.18 (d,
3H, J = 0.7 Hz); 13C NMR (300 MHz, CDCl3) d 149.5, 144.5, 138.5, 133.2, 132.9,
132.6, 131.3, 130.3, 129.7, 129.2, 129.1, 129.0, 128.8, 128.8, 128.7, 128.7, 128.6,
127.9, 127.4, 126.9, 126.8, 125.9, 121.8, 118.9, 107.0, 47.7, 12.7; HRMS (ESI+)
m/z calcd for C23H21N2 (MH+) 325.1705, found 325.1708.
26. 4-(1-Benzyl-2-methyl-5-phenyl-1H-pyrrol-3-yl)pyridine (30): orange oil; 1H
NMR (300 MHz, CDCl3) d 8.49 (d, 2H, J = 5.9 Hz), 7.43–7.12 (m, 10H), 6.92 (d,
2H, J = 7.3 Hz), 6.57 (s, 1H), 5.23 (s, 2H), 2.27 (s, 3H); 13C NMR (300 MHz, CDCl3)
d 157.5, 150.3, 144.5, 139.1, 135.0, 133.3, 131.5, 130.3, 129.6, 129.5, 129.3,
129.3, 129.1, 128.9, 127.9, 127.8, 126.2, 126.1, 122.3, 119.5, 108.7, 47.9, 12.3;
HRMS (ESI+) m/z calcd for C23H21N2 (MH+) 325.1705 found 325.1702.
27. 2-(1-Benzyl-5-methyl-2-phenyl-1H-pyrrol-3-yl)quinoline (31): Pale yellow oil;
1H NMR (300 MHz, CDCl3) d 8.12 (d, 1H, J = 8.8 Hz), 7.73 (d, 1H, J = 8.5 Hz),
7.67–7.63 (m, 2H), 7.43–7.23 (m, 9H), 6.98–6.91 (m, 4H), 5.05 (s, 2H), 2.25 (s,
3H); 13C NMR (300 MHz, CDCl3) d 155.8, 148.7, 138.7, 135.2, 133.5, 133.4,
131.5, 130.3, 129.4, 129.2, 128.9, 128.4, 127.5, 127.3, 126.5, 126.0, 125.3, 123.1,
121.3, 108.5, 47.8, 12.8; HRMS (ESI+) m/z calcd for C27H23N2 (MH+) 375.1861,
found 375.1861.
C
18H19N2 (MH+) 263.1548, found 263.1546.
16. 2-(1-Benzyl-2,5-dimethyl-1H-pyrrol-3-yl)quinoline (20): Pale orange oil; 1H
NMR (300 MHz, CDCl3) d 8.07 (d, 2H, J = 8.5 Hz), 7.75 (d, 1H, J = 7.8 Hz), 7.65
(t, 2H), 7.43 (t, 1H), 7.36–7.24 (m, 3H), 7.02 (d, 2H, J = 7.1 Hz), 6.49 (s, 1H), 5.13
(s, 2H), 2.71 (s, 3H), 2.24 (s, 3H); 13C NMR (300 MHz, CDCl3) d 156.8, 148.6,
138.1, 135.9, 129.4, 129.3, 129.2, 129.1, 128.5, 127.6, 127.4, 126.2, 126.0, 125.1,
120.9, 120.3, 106.8, 47.0, 12.7, 12.1; HRMS (ESI+) m/z calcd for C22H21N2 (MH+)
313.1705, found 313.1707.
17. 2-(1-Benzyl-2,5-diphenyl-1H-pyrrol-3-yl)pyridine (21): Bright yellow solid, mp
122–124 °C; 1H NMR (300 MHz, CDCl3) d 8.60 (d, 1H, J = 3.9 Hz), 7.52–7.49 (m,
2H), 7.38–7.25 (m, 9H), 7.11–7.07 (m, 3H), 7.04 (s, 1H), 6.97–6.92 (m, 1H), 6.82
(d, 1H, J = 8.1 Hz), 6.68–6.65 (m, 2H), 5.12 (s, 2H); 13C NMR (300 MHz, CDCl3) d
155.1, 149.6, 139.0, 136.4, 135.7, 134.4, 133.6, 133.2, 131.4, 129.4, 128.9, 128.7,
128.5, 128.3, 127.5, 127.1, 126.3, 124.0, 122.0, 120.3, 110.2, 48.9; HRMS (ESI+)
m/z calcd for C28H23N2 (MH+) 387.1861, found 387.1853.
28. 2-(1-Benzyl-2-methyl-5-phenyl-1H-pyrrol-3-yl)quinoline (32): Pale orange oil;
1H NMR (300 MHz, CDCl3) d 8.13–8.09 (m, 2H), 7.79–7.65 (m, 4H), 7.48–7.26
(m, 8H), 7.08 (d, 2H, J = 6.8 Hz), 6.84 (s, 1H), 5.25 (s, 2H), 2.71 (s, 3H); 13C NMR
(300 MHz, CDCl3) d 156.5, 148.6, 138.6, 136.0, 134.9, 133.5, 131.4, 129.4, 129.3,
129.2, 129.1, 128.8, 127.7, 127.4, 126.3, 126.0, 125.3, 121.8, 120.9, 109.0, 48.1,
12.4; HRMS (ESI+) m/z calcd for C27H23N2 (MH+) 375.1861, found 375.1864.
18. 3-(1-Benzyl-2,5-diphenyl-1H-pyrrol-3-yl)pyridine (22): White solid, mp 116–
117 °C; 1H NMR (300 MHz, CDCl3) d 8.57 (d, 1H, J = 2.0 Hz), 8.32 (dd, 1H, J = 4.9,